Gentherm Incorporated Reports Strong Q2 Performance with Strategic Acquisitions and Market Expansion
Gentherm Inc (THRM) delivered strong performance in the second quarter of 2026, achieving a 12.7% organic growth despite a global decline in light vehicle production by 3%. The company attributed this success to high adoption rates for its Lumbar and Massage solutions in China and North America. Gentherm also expanded into new markets through strategic acquisitions like Innovative Medical Equipment (IME), which provides access to the Veterans Administration healthcare channel, and is leveraging core automotive technology for medical applications such as ThermAffyx. The company anticipates a transformational shift with its pending acquisition of Modine Performance Technologies, expected in early Q4 2026. This merger will diversify Gentherm’s revenue mix by reducing light vehicle exposure from 97% to around 63%, while expanding into commercial vehicles and power generation markets. The company aims for over $3.5 billion in revenue by 2030, supported by an estimated $1 billion in cumulative unlevered free cash flow. Operational adjustments included a new operating system focused on efficiency gains and margin expansion, along with a significant stock repurchase program of up to $400 million over three years. Gentherm also secured $800 million in financing for the Modine acquisition while maintaining target leverage ratios.
Tickers: $THRM
Topics: automotive financial targets medical technology mergers and acquisitions